BIOPHYTIS SA-ADR (BPTS)
US09076G2030 - ADR
| TTM (2023-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.58M | -17.03M | -24.22M | -31.25M | -25.52M | |||
| Depreciation Amortization | 590.00K | 803.00K | 484.00K | 311.00K | 280.00K | |||
| Change In Working Capital | -240.00K | 1.01M | 540.00K | -52.00K | 4.44M | |||
| Interest Paid | 220.00K | 460.00K | 662.00K | 562.00K | 628.00K | |||
| Other non cash items | 2.35M | 2.34M | 4.21M | 7.19M | 11.05M | |||
| OPERATING CASH FLOW | -16.89M | -12.87M | -18.99M | -23.80M | -9.74M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -210.00K | -220.00K | -141.00K | -344.00K | -214.00K | |||
| Other Investing Activity | -930.00K | 590.00K | 124.00K | 12.50M | -12.50M | |||
| INVESTING CASH FLOW | -1.13M | 370.00K | -17.00K | 12.16M | -12.71M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.14M | 2.37M | 7.43M | 17.50M | 5.34M | |||
| Stock Issued/Repurchased | N/A | 5.54M | N/A | 16.58M | 23.49M | |||
| Other Financing Activity | -300.00K | -884.00K | -1.29M | -4.37M | -6.87M | |||
| FINANCING CASH FLOW | 4.13M | 7.03M | 6.13M | 29.71M | 21.95M | |||
| Exchange Rate Effect | -80.00K | -9.00K | -3.00K | -1.00K | 13.00K | |||
| CHANGE IN CASH | -13.97M | -5.49M | -12.87M | 18.08M | -490.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.89M | -12.87M | -18.99M | -23.80M | -9.74M | |||
| Capital Expenditure | -210.00K | -220.00K | -141.00K | -344.00K | -214.00K | |||
| FREE CASH FLOW | -17.10M | -13.09M | -19.13M | -24.14M | -9.96M | |||
All data in EUR